West Pharmaceutical Services, Inc. (NYSE:WST) Declares $0.22 Quarterly Dividend

West Pharmaceutical Services, Inc. (NYSE:WST) announced a quarterly dividend on Monday, February 16th. Stockholders of record on Wednesday, April 29th will be given a dividend of 0.22 per share by the medical instruments supplier on Wednesday, May 6th. This represents a c) dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date of this dividend is Wednesday, April 29th.

West Pharmaceutical Services has increased its dividend by an average of 0.1%per year over the last three years. West Pharmaceutical Services has a dividend payout ratio of 12.4% indicating that its dividend is sufficiently covered by earnings. Equities research analysts expect West Pharmaceutical Services to earn $7.86 per share next year, which means the company should continue to be able to cover its $0.88 annual dividend with an expected future payout ratio of 11.2%.

West Pharmaceutical Services Stock Up 1.1%

WST stock traded up $2.59 during mid-day trading on Wednesday, reaching $245.78. The company had a trading volume of 201,977 shares, compared to its average volume of 1,097,995. West Pharmaceutical Services has a fifty-two week low of $187.43 and a fifty-two week high of $322.34. The firm has a fifty day simple moving average of $260.12 and a 200 day simple moving average of $261.81. The company has a debt-to-equity ratio of 0.06, a quick ratio of 2.34 and a current ratio of 3.02. The company has a market capitalization of $17.68 billion, a price-to-earnings ratio of 36.27, a price-to-earnings-growth ratio of 3.27 and a beta of 1.18.

West Pharmaceutical Services (NYSE:WST) last announced its quarterly earnings data on Thursday, February 12th. The medical instruments supplier reported $2.04 earnings per share for the quarter, beating analysts’ consensus estimates of $1.83 by $0.21. West Pharmaceutical Services had a net margin of 16.06% and a return on equity of 17.90%. The business had revenue of $805.00 million for the quarter, compared to analyst estimates of $795.70 million. During the same period last year, the business earned $1.82 EPS. The company’s revenue was up 7.5% on a year-over-year basis. West Pharmaceutical Services has set its FY 2026 guidance at 7.850-8.200 EPS. Analysts forecast that West Pharmaceutical Services will post 6.62 earnings per share for the current fiscal year.

West Pharmaceutical Services Company Profile

West Pharmaceutical Services, Inc is a global developer and manufacturer of components, systems and services that enable the containment and delivery of injectable drugs. The company focuses on high-quality packaging and delivery solutions for the pharmaceutical and biotech industries, producing primary drug packaging components and specialized drug delivery devices used for vaccines, biologics and other injectable therapies. West is known for its elastomeric closures, seals and polymer components that maintain sterility and compatibility with sensitive drug formulations.

In addition to component manufacturing, West provides engineered delivery systems and support services across the product lifecycle.